Join our new priority response service
Complex regulatory challenges for lab grown ingredients
New QP loyalty scheme launched
Diversity & Inclusion
Insights & resources
The need to identify and characterise unknown impurities in pharmaceutical products is of paramount importance. Characterisation is required to allow for toxicological assessment of degradation products and allows greater understanding of degradation pathways which may influence the efficacy of the treatment.
A wide range of analytical techniques may be called upon during characterisation studies, depending on the nature and size of the impurity molecule, the complexity of the formulation matrix and the level at which the impurity is observed.
This webinar will take a deep dive into nuclear magnetic resonance (NMR) spectroscopy and accurate mass liquid chromatography mass spectrometry (LC-MS) to leverage knowledge in the assessment and characterisation of this industry critical scientific challenge.
Catherine Frankis is a senior scientist working across the functional ingredients and investigative analysis teams. Catherine has worked on a wide variety of projects, including the development and validation of new analytical methods within the food, pharmaceutical and cosmetic industries.
Daniel Nicolau has taken a leading role in the delivery of RSSL's LC-MS techniques and our nitrosamines testing service. A technical specialist in key analytical fields, Daniel's chemical knowledge, resourcefulness and expertise enables him to assist clients with their regulatory submissions and troubleshooting needs.
Switchboard: +44 (0)118 918 4000
+44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.